top banner imagetop banner mobile image


The TherapeuticsMD management team has extensive experience and a proven track record of success in product innovation, development, and commercialization, includingwithin the women’s healthcare industry. We believe that our leadership’s ability to leverage our robust intellectual property, product pipeline, and entrepreneurial spirit will continue to guide the company into a promising future.


    • Robert G. Finizio

      Chief Executive Officer, Co-Founder, and Director
      Robert (Rob) G. Finizio is Chief Executive Officer, Co-Founder, and Director of TherapeuticsMD Inc., an innovative women’s health pharmaceutical company. With over 20 years of healthcare experience, Rob started his career in an operational role at Endoscopy Specialist, Inc. (ESI), a leader in laparoscopic equipment outsourcing and intraoperative technical support. During his tenure at ESI, Rob advanced to a regional management role, eventually leaving to join Omnicell Technologies (OMCL), a leader in pharmacy automation. While at Omnicell, Rob served as a sales director, ultimately leaving the company to co-found CareFusion in 2001. CareFusion was a pioneer in hospital patient safety systems for Medication, Blood, and Specimen verification at the point of care. The company was successfully sold to Cardinal Health in 2006. Rob co-founded TherapeuticsMD (TXMD) in 2008, combining his background in women’s healthcare, pharmaceutical technology, clinical software, and patient safety. Today, TXMD is a leader in women’s health, pharmaceutical development, and commercialization. In 2011, Rob took TXMD public, with a current market capitalization of over a billion dollars. Since inception, Rob raised more than $500 million in capital and listed TXMD on the NYSE before transferring to the Nasdaq in 2017. Rob sits on the Board of Directors for two non-profit organizations, BioFlorida and the Boca Raton Police Foundation. Prior to his healthcare career, Rob, a University of Miami graduate who earned a Bachelor of Arts degree majoring in Premed and Psychology, taught English in Osaka, Japan.
      • John Milligan

        John Milligan is President of TherapeuticsMD. An experienced, entrepreneurial healthcare executive, Mr. Milligan has more than 20 years of successful sales, management, business development, and operations experience. Throughout his career, he has leveraged his knowledge of the complex healthcare environment to create numerous successful companies. He co-founded clinical technology vendor CareFusion in 2001, selling it to Cardinal Health in 2006. Mr. Milligan held executive sales and operation management positions with Omnicell, Inc., a provider of clinical workflow solutions; Serving Software Inc.; and HBOC. McKesson Corporation eventually acquired the latter two companies. Mr. Milligan received his Bachelor of Science degree in Management Engineering from the United States Naval Academy.
        • James C. D’Arecca

          Chief Financial Officer
          James C. D’Arecca is Chief Financial Officer at TherapeuticsMD. Prior to joining TherapeuticsMD, Mr. D'Arecca served as the Senior Vice President and Chief Accounting Officer of Allergan plc (formerly known as Actavis plc) from August 2013 until its merger with AbbVie Inc. in May 2020. Mr. D’Arecca was a key member of the finance team through Allergan’s journey from a generics manufacturer (Watson/Actavis) to a leading global pharmaceutical company. Mr. D’Arecca joined Actavis from Bausch & Lomb, where he served as its Chief Accounting Officer. Prior to Bausch & Lomb, he served in various roles of increasing responsibility at Merck & Co. Inc. and Schering-Plough in finance and business development. He also spent 13 years with PricewaterhouseCoopers, with an industry focus on pharmaceuticals, medical devices, and consumer products. Mr. D'Arecca earned his MBA from Columbia University, his B.S. in accounting from Rutgers University, and is a Certified Public Accountant.
          • Dawn Halkuff

            Chief Commercial Officer
            Dawn Halkuff has held numerous senior level commercial and marketing positions over 20 years. Most recently, she was Senior Vice President of the Pfizer Consumer Healthcare Wellness Organization and a member of the Consumer Global Leadership Team. Ms. Halkuff was also commercial lead for sales and marketing of the Pfizer Women’s Health Division, focusing on the company’s reinvestment in hormone therapy treatment, including Premarin Vaginal Cream® and oral hot flash treatments. From 2005 to 2010, Ms. Halkuff was Head of Global Innovation at Weight Watchers International, where she created new weight-loss products, services, and solutions for women worldwide. She holds a BA in Psychology from University of Connecticut and an MBA from Pennsylvania State University.
            • Brian Bernick, M.D., F.A.C.O.G.

              Dr. Brian Bernick is Co-Founder at TherapeuticsMD. Dr. Bernick is a practicing, board-certified obstetrician/gynecologist with over 20 years of clinical medical experience. Dr. Bernick currently serves on the American College of Obstetricians and Gynecologists’ (ACOG) national committee on Professional Liability. Dr. Bernick was the Department Chair of Obstetrics and Gynecology at Boca Raton Regional Hospital and served on that hospital’s Medical Executive Board as well as the Board of Directors of the Palm Beach Medical Society and VitalMD Group Holding, LLC, the largest physician-owned and managed obstetricians/gynecologists group in Florida. Dr. Bernick is the recipient of several national and regional awards, including recognition by his peers as one of the top doctor’s in his specialty by Castle Connolly as well as the recipient of the American Medical Association Foundation’s Leadership Award. Dr. Bernick has numerous publications in peer-reviewed journals as well as having presented original research at numerous medical conferences. Dr. Bernick holds 14 patents focusing on drug therapies and analysis. Dr. Bernick is an associate professor of Florida Atlantic University College of Medicine. Dr. Bernick holds a Bachelor of Arts degree in Economics from Northwestern University, received his Doctorate in Medicine from the Chicago Medical School, and completed his residency at the University of Pennsylvania.
              • DEVELOPMENT TEAM

                • Sebastian Mirkin, M.D.

                  Chief Medical Officer
                  Dr. Sebastian Mirkin is Chief Medical Officer at TherapeuticsMD. Dr. Mirkin has more than 15 years of clinical development and medical affairs experience in women’s health. His experience includes Global Lead of Women’s Health Clinical Research at Pfizer; Senior Director Clinical Research, Women’s Health at Wyeth; and Global Lead Medical Services at Organon. Dr. Mirkin oversaw the development and successful marketing authorization of several novel medicines including Duavee®, Conbriza®, Lybrel® and Premarin® Vaginal Cream in the United States, Europe, and Japan. Dr. Mirkin holds a Doctor of Medicine degree from National University, Argentina. Trained in obstetrics/gynecology, Dr. Mirkin completed his fellowship in Reproductive Medicine at the Jones Institute of Reproductive Medicine in Norfolk, Virginia, and was involved in several NIH and pharmaceutical-sponsored clinical trials in reproduction, contraception, and menopausal health. Dr. Mirkin’s awards include the New Young Investigator Award from the North American Menopause Society and the Burroughs Fellowship Award from the Society for Gynecological Investigation. Published extensively in the fields of menopause, contraception, and reproductive endocrinology, Dr. Mirkin is an ad hoc reviewer for multiple women’s health-related journals.
                  • Marlan Walker, J.D.

                    General Counsel
                    Marlan Walker is General Counsel at TherapeuticsMD. Previously, he was in-house IP counsel for Medicis Pharmaceutical Corporation, which was acquired by Valeant Pharmaceutical International in December 2012. Mr. Walker has extensive experience in private practice at a number of nationally recognized law firms in addition to his experience as an in-house attorney. Mr. Walker’s particular expertise is in the life science industries, including long-term portfolio strategy and management, patent preparation and prosecution, contract negotiation and drafting, life-cycle management, and Hatch-Waxman. He received his Bachelor’s and Master of Science (Molecular Biology) degrees from Brigham Young University. Mr. Walker also received a Juris Doctor degree from the Arizona State University Sandra Day O’Connor College of Law and Master of Laws degree in intellectual property law from The George Washington University Law School.
                    • Bharat Warrier

                      Chief Manufacturing Officer

                      Bharat Warrier is Chief Manufacturing Officer at TherapeuticsMD. He has been with TherapeuticsMD since 2014 previously holding the position of Vice President of Manufacturing and Product Development. He has been the functional lead on several FDA submissions while also spearheading the scale-up and commercial manufacturing of products--both in-house and at contract manufacturing facilities. Prior to joining TherapeuticsMD, Mr. Warrier held positions at Valeant Pharmaceuticals, Medicis Pharmaceuticals, Novartis Consumer Health, and Morton Grove Pharmaceuticals. He has more than 15 years of pharmaceutical experience in the areas of manufacturing, technical services, formulation, and process development.

                      Mr. Warrier earned a Bachelor of Pharmacy degree from Sri Ramachandra University, India, an M.S. degree in Pharmaceutical Sciences from the University of Missouri - Kansas City, and a Master’s Certificate in Regulatory Affairs and Quality Assurance from Purdue University.

                      • Jennifer Wilson

                        Vice President, Business Development

                        Jennifer Wilson began her healthcare career through investment banking, working in the Bank of America Merrill Lynch Healthcare Group. Her vast experience in large scale transactions across the financial spectrum includes IPO’s, mergers, acquisitions, divestitures, public debt offerings, leveraged buyouts and licensing agreements. Her expertise grew at Anthem where she directed strategic transactions totaling over $78 billion in deal value.

                        Jennifer joined TherapeuticsMD in 2016. During her time with the company, she has championed projects such as the company’s move into contraception with ANNOVERA. She was instrumental in expanding the company’s innovative menopause products to women outside of the U.S. and across the world by executing a world-wide out-licensing transaction for the company’s menopause franchise.

                        • OPERATIONS TEAM

                          • Mitchell Krassan

                            Chief Strategy & Performance Officer
                            Mitchell Krassan is Chief Strategy & Performance Officer at TherapeuticsMD. He has 25 years of operational and financial management experience. Prior to joining TherapeuticsMD, Mr. Krassan was a principal in EquiMark Limited, a private investment company that provided its portfolio companies with resources in the form of executive management, marketing and financial operations. Earlier on, Mr. Krassan was Chief Financial Officer and Chief Operations Officer of The Reich Group, a fully integrated direct marketing company with a focus on strategic planning, research, and operations. Mr. Krassan started his career in the big six public accounting where he rose to the level of manager at Arthur Andersen, focusing on operational consulting for closely held companies. Mr. Krassan received his Bachelor of Science degree in Accounting from the University of Maryland and his Master of Business Administration in Management from New York University.
                            • Adam Miller

                              Chief Information Officer & Chief Information Security Officer

                              Adam Miller is Chief Information Officer & Chief Information Security Officer at TherapeuticsMD. Mr. Miller has more than 16 years of experience in the information technology field with 13+ years specifically in healthcare IT. Prior to becoming CIO, Mr. Miller served as Vice President of Information Technology at TherapeuticsMD and has been devoted to leading the information technology department since May of 2011. Mr. Miller has been responsible for all aspects of IT including governance and planning, IT solutions management and development, infrastructure, security, and operations.

                              Before joining TXMD, Mr. Miller was a Consultant for Quilogy, a healthcare-focused Microsoft Gold Partner consulting firm. While at Quilogy, Mr. Miller spent time on projects for Kindred Healthcare, the University of Kentucky, and Microsoft filling various roles in project management, development, business analysis, administration, and training. Mr. Miller has also held various IT-related roles with Healthcare Recoveries, Louisville Gas & Electric, and Brown-Forman.

                              Mr. Miller has a BSBA in Computer Information Systems with a Concentration in Information Security from the University of Louisville’s College of Business. He is also an active member in the South Florida leadership and information technology communities.

                              • Chris Gish

                                Senior Vice President, Sales

                                Chris Gish is a seasoned biopharmaceutical sales executive with over 28 years of experience leading teams and driving results. His career includes leadership positions as Vice President of Sales at Alder Biopharmaceuticals, Sunovion Pharmaceuticals as head of US sales leading three specialty sales teams, and more than 20 years at Pfizer culminating in his role leading promotional assets for the US Brands Group (Upjohn).

                                During his career Chris has had experience with multiple brands in the women’s healthcare space and the complexities of a hub service model and specialty pharmacy reimbursement. He served as a Lieutenant in the US Navy prior to beginning his career in the pharmaceutical industry. Chris earned his bachelor’s degree in liberal arts from the University of Missouri and his Master in Business Administration from Golden Gate University.